Latest Islets of Langerhans Stories
Research and Markets (http://www.researchandmarkets.com/research/d99eac/competitor_analysi) has announced the addition of the "Competitor Analysis: Emerging Diabetes Drugs" report to their offering.
Launching a counter-attack on the immune response that causes insulin-dependent diabetes may provide a revolutionary new way of treating the disease, research has shown.
MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, has appointed Brian D. Conn to the positions of Vice President Corporate Finance and Chief Financial Officer. Mr.
Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced that Professor Bob Elliott, Medical Director of LCT, will host a seminar on Friday, August 8, 2008, in Auckland, New Zealand for world leading medical scientists and specialists to discuss current developments with porcine islet transplant technologies.
Tissera, Inc. (OTCBB:TSSR) reports that on July 8, 2008, it has entered into a bridge loan agreement with an accredited investor, who was a participant in the Company's December 2006 fund raising.
MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report recent safety and efficacy data.
Osiris Therapeutics, Inc.
Scientists at Washington University School of Medicine in St. Louis working with diabetic mice have examined in unprecedented detail the immune cells long thought to be responsible for type 1 diabetes.
Kinexum Metabolics, Inc. (KMI) announced two abstracts will be presented on INGAP Peptide at the Keystone Symposia on Islet and Beta Cell Biology to be held April 6-10, 2008.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.